Using TCGA cohorts, we also confirmed that CaMKK2 expression was associated with the survival rate of patients with lung cancer, with a higher CaMKK2 expression associated with a decreased patient survival rate (Figure S5F, Supporting Information). This evidence concerns the gene CAMKK2 and lung carcinoma.